Conditions: semaglutide · 30 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs without…
clinical-trials
Page 21 of 32 · 745 questions tagged clinical-trials.
The case in front of me: ATTAIN-1 · injection-site erythema · 36 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
For reference: REDEFINE-1 · nausea · 2.4 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: ATTAIN-1 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Stated plainly: cagrilintide · REDEFINE-1. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather…
What I am working with: SURMOUNT-OSA · nausea. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
I have three data points across nine months, which I hope is enough to see a trend. I can do the algebra. I am not confident about the conversion factors. If there is…
The trend is what I care about; individual weeks are obviously noise. I would like to know whether this claim survives contact with evidence. If the answer is "nobody…
Setup, so nobody has to ask: cagrilintide · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
For reference: PIONEER-1 · headache · 25 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: STEP 2 · hair thinning · 1 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I have the document in front of me and I can read the numbers. What I cannot…
Concretely: TRIUMPH-1 · vomiting. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
The particulars: 10 mg · ecnoglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than on…
The specifics, since they change the answer: dizziness · tirzepatide · SURPASS-2. I have the document in front of me and I can read the numbers. What I cannot do is…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. Please show the division. I want to check my own against yours. I…
The particulars: STEP 2 · constipation. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I have worked this out and I would like someone to find…
Stated plainly: STEP 5 · vomiting · 2.4 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
Conditions: 25 mg · oral semaglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
What I am working with: SOUL · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Stated plainly: nausea · a GLP-1 receptor agonist · STEP 8. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
The specifics, since they change the answer: ATTAIN-1 · orforglipron. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
Setup, so nobody has to ask: TRIUMPH-1 · retatrutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…